Shopping Cart
Remove All
Your shopping cart is currently empty
Butabindide (UCL-1397) is a potent, selective inhibitor of tripeptidyl peptidase II (TPP II), with Ki values of 10 μM and 7 nM for TPP I and TPP II, respectively, inhibiting TPP II to protect CCK-8 against inactivation [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Butabindide (UCL-1397) is a potent, selective inhibitor of tripeptidyl peptidase II (TPP II), with Ki values of 10 μM and 7 nM for TPP I and TPP II, respectively, inhibiting TPP II to protect CCK-8 against inactivation [1] [2]. |
| In vitro | Butabindide (also known as UCL-1397; concentration range: 0-24 nM; applied to rat cerebral cortex membranes) effectively inhibits tripeptidyl-peptidase II (TPP II) activity in cerebral membranes. |
| In vivo | Butabindide (UCL-1397; 10 mg/kg; i.v.; for 20 min) effectively inhibits the degradation of CCK-8 within the gastrointestinal tract, enhancing satiety in mice [2]. Using a mouse model (25-30 g), intravenous administration of the compound at 10 mg/kg over 20 minutes reduced food intake and induced satiation behaviors. |
| Molecular Weight | 303.4 |
| Formula | C17H25N3O2 |
| Cas No. | 175553-48-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.